Bill and Melin­da Gates Foun­da­tion backs lit­tle-known biotech go­ing af­ter Pfiz­er, Mer­ck on pneu­mo­coc­cal vac­cine

The Bill and Gates Melin­da Foun­da­tion has raised big mon­ey over its life­time to sup­port med­i­cines for poor­er coun­tries, and it an­nounced its lat­est in­vest­ment on Wednes­day.

In­vent­prise, a biotech lo­cat­ed in the Seat­tle sub­urbs, has se­cured a promise of up to $90 mil­lion from the non­prof­it, aimed at boost­ing de­vel­op­ment of its pneu­mo­coc­cal con­ju­gate vac­cine can­di­date, the Gates Foun­da­tion said Wednes­day morn­ing. The foun­da­tion ex­pects the cash will cov­er Phase I and Phase II stud­ies for the vac­cine, dubbed IVT-25.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER